Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
SLC35A2 overexpression
i
Other names:
SLC35A2, Solute Carrier Family 35 Member A2, UGTL, UGT, UDP-Galactose Translocator, UDP-Gal-Tr, UGALT, UGAT, UGT1, UGT2, Solute Carrier Family 35 (UDP-Galactose Transporter), Member A2, Solute Carrier Family 35 (UDP-Galactose Transporter), Member 2, UDP-Galactose Transporter, CDG2M, CDGX
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
7355
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
SLC35A2 overexpression
Lung Adenocarcinoma
SLC35A2 overexpression
Lung Adenocarcinoma
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
SLC35A2 overexpression
Bladder Cancer
SLC35A2 overexpression
Bladder Cancer
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
SLC35A2 overexpression
Cutaneous Melanoma
SLC35A2 overexpression
Cutaneous Melanoma
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
SLC35A2 overexpression
Lung Non-Small Cell Squamous Cancer
SLC35A2 overexpression
Lung Non-Small Cell Squamous Cancer
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.